Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 6:44 PM
Ignite Modification Date:
2025-12-24 @ 6:44 PM
NCT ID:
NCT04930757
Brief Summary:
The main objective is to quantify the population of reverse migrating neutrophils in patients with COVID-19.
Detailed Description:
This is a non-interventional transversal research whose main objective is to quantify the population of reverse migrating neutrophils in patients with COVID-19.
Design:
A multicentric (3 sites) clinical trial
Sample size :
200 patients
Population concerned:
Patients hospitalized in intensive care with SARS-CoV-2 infection confirmed by RT-PCR from a nasopharyngeal swab.
Duration of participation (treatment + follow-up): until the patient is discharged from the ICU and within 2 months top.
No interim analysis is planned. Analysis will be performed at the end of the study.
Study:
NCT04930757
Study Brief:
Protocol Section:
NCT04930757